GB Patent

GB201908430D0 — Cgrp antagonist compounds

Assigned to Nxera Pharma UK Ltd · Expires 2019-07-24 · 7y expired

What this patent protects

Patent listed against Qulipta.

Drugs covered by this patent

Patent Metadata

Patent number
GB201908430D0
Jurisdiction
GB
Classification
—
Expires
2019-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Nxera Pharma UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.